Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
CAPS Rating:
The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.
RSS Headlines
Fool UK
Recs
promise of more upside